Sign In
Last checked at 
3 Feb 2009 11:32
3 February 2009
PROVEXIS plc
("Provexis" or the "Company")
EXTENSION OF EXCLUSIVE FRUITFLOW® TECHNOLOGY ASSESSMENT AGREEMENT WITH THE COCA-COLA COMPANY
Provexis plc (PXS.L), which discovers, develops and licenses scientifically-proven functional food, medical food and dietary supplement technologies, announces the extension of its exclusive technology assessment agreement for its patented Fruitflow® anti-thrombotic technology with The Coca-Cola Company until 31 March 2009.
The exclusivity agreement covers all beverages, with the exception of mini-drinks. During the assessment period both parties will continue a programme of work including commercial and regulatory assessment.
-ends-
For further information please contact:
Stephen Moon, Chief Executive
Provexis plc Tel: 01753 752290
Tom Griffiths/Alasdair Younie Tel: 020 7012 2000
Arbuthnot Securities
Follow the stocks
